ADOC
ADOC's Overview
Adocia (Euronext Paris: FR0011184241 – ADOC) is a clinical-stage biotechnology company specializing in the development of innovative formulations of already-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. By leveraging its proprietary BioChaperone® technological platform, Adocia aims to enhance the effectiveness and/or usability of therapeutic proteins, thereby providing better treatment options for patients. Their pipeline includes formulations for prandial and basal insulins, as well as combinations of insulins with other hormones like pramlintide and glucagon.
Where is ADOC's Headquarters?
HQ Function
Serves as the central hub for Adocia's research and development, clinical development programs, corporate administration, and strategic operations.
Notable Features:
The headquarters houses state-of-the-art laboratories for formulation research, preclinical studies, and analytical development, alongside modern office spaces designed for collaboration.
Work Culture:
Adocia fosters a work environment centered on scientific innovation, collaboration, and a commitment to addressing unmet medical needs. The culture encourages rigorous research and a patient-focused approach.
HQ Significance:
The Lyon headquarters is strategically important as it centralizes Adocia's core BioChaperone® technology platform development and the management of its global clinical trials and partnerships.
Values Reflected in HQ: The headquarters reflects Adocia's commitment to scientific excellence, innovation in drug delivery, and operational efficiency in pursuing therapeutic advancements.
Location:
Adocia primarily operates from its headquarters in Lyon, France, which supports its global activities. While it does not maintain a large network of international offices, its global reach is achieved through international clinical trials conducted in multiple countries, collaborations with global pharmaceutical partners for development and commercialization, and engagement with the international scientific and investment communities.
Street Address:
115 Avenue Lacassagne
City:
Lyon
State/Province:
Auvergne-Rhône-Alpes
Country:
France
ADOC's Global Presence
Buying Intent Signals for ADOC
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of ADOC
As of April 2025, ADOC' leadership includes:
Investors of ADOC
ADOC has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Adocia has strengthened its executive and key leadership team over the past 12-18 months with strategic appointments in finance, medical, and clinical operations roles to support its pipeline advancement. No major executive departures have been publicly announced during this period.
New Appointments:
Technology (Tech Stack) used by ADOC
Discover the tools ADOC uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
ADOC Email Formats and Examples
Adocia likely utilizes a standard corporate email format. Common formats include the first initial followed by the last name, or first name separated by a dot from the last name, combined with the '@adocia.com' domain.
[first_initial][last]@adocia.com
Format
jsmith@adocia.com
Example
85%
Success rate
News and media
adocia.com • May 2, 2024
Adocia Announces Positive Topline Results from the Phase 2 Clinical Study of M1Pram in Participants with Type 1 Diabetes and Obesity
Adocia reported positive primary endpoint results for its Phase 2 study (M1PRAM ROY) with M1Pram (ADO09) in people with type 1 diabetes and obesity or overweight. The study showed significant weight loss and improved glycemic control....more
adocia.com • March 7, 2024
Adocia Presents New Positive Clinical Data on BioChaperone® Lispro at ATTD 2024 Conference
Adocia presented new positive clinical data from a Phase 1 study on BioChaperone® Lispro (BC Lispro), an ultra-rapid insulin, at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Florence, Italy....more
adocia.com • February 20, 2024
Adocia Receives Milestone Payment from Tonghua Dongbao
Adocia announced the receipt of a milestone payment from its Chinese partner Tonghua Dongbao Pharmaceuticals Co., Ltd. This payment was triggered by the Investigational New Drug (IND) approval by the NMPA for BioChaperone® Combo in China....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including ADOC, are just a search away.